• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周动脉疾病的时间趋势和死亡率模式:对2014年至2021年哈萨克斯坦住院患者的综合分析

Temporal Trends and Mortality Patterns in Peripheral Arterial Disease: A Comprehensive Analysis of Hospitalized Patients in Kazakhstan between 2014 and 2021.

作者信息

Zhakhina Gulnur, Sakko Yesbolat, Yerdessov Sauran, Aimyshev Temirgali, Makhammajanov Zhalaliddin, Abbay Anara, Vinnikov Denis, Fakhradiyev Ildar, Yermakhanova Zhanar, Solak Yalcin, Salustri Alessandro, Gaipov Abduzhappar

机构信息

Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.

Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana, Kazakhstan.

出版信息

J Epidemiol Glob Health. 2024 Dec;14(4):1609-1618. doi: 10.1007/s44197-024-00313-6. Epub 2024 Oct 14.

DOI:10.1007/s44197-024-00313-6
PMID:39400655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11652560/
Abstract

BACKGROUND

Peripheral artery disease (PAD) is a global health concern associated with arterial narrowing or blockage, leading to significant morbidity and mortality. The aim of this study is to assess the disease burden and trends in mortality utilizing nationwide administrative health data.

METHODS

This retrospective study utilized data from the Unified National Electronic Healthcare System (UNEHS) from 2014 to 2021. Patients meeting PAD criteria were included, with demographic and clinical data analyzed. Cox regression and Competing Risk Analysis assessed mortality risks.

RESULTS

Between 2014 and 2021, 19,507 individuals were hospitalized due to PAD, with 8,332 (43%) being women and 11,175 (57%) men. The incidence of PAD increased markedly over the observation period, rising from 79 individuals per million population (PMP) in 2014 to 309 PMP in 2021. Concurrent heart failure (HF), acute myocardial infarction (AMI), diabetes, and essential hypertension were prevalent in 50%, 27%, 27%, and 26% of the PAD patients, respectively. Competing Risk Analysis showed a subdistribution hazard ratio (SHR) of 6.53 [95% CI: 4.65-9.19] for individuals over 80 years. Heart failure was associated with lower all-cause HR [0.80, 95% CI: 0.76-0.86, p < 0.001] but higher SHR [1.30, 95% CI: 1.18-1.44, p < 0.001]. Comorbidities such as heart failure, stroke, and acute myocardial infarction significantly increased mortality risks, while essential hypertension was associated with lower risk of death.

CONCLUSION

The significant rise in the incidence rate of PAD underscores the growing burden of the disease, highlighting the urgent need for targeted preventive and management strategies in Kazakhstan.

摘要

背景

外周动脉疾病(PAD)是一个全球性的健康问题,与动脉狭窄或阻塞相关,会导致严重的发病率和死亡率。本研究的目的是利用全国性的行政卫生数据评估疾病负担和死亡率趋势。

方法

这项回顾性研究使用了2014年至2021年统一国家电子医疗系统(UNEHS)的数据。纳入符合PAD标准的患者,并对人口统计学和临床数据进行分析。采用Cox回归和竞争风险分析评估死亡风险。

结果

2014年至2021年期间,有19507人因PAD住院,其中女性8332人(43%),男性11175人(57%)。在观察期内,PAD的发病率显著上升,从2014年的每百万人口79人(PMP)增至2021年的309 PMP。分别有50%、27%、27%和26%的PAD患者并发心力衰竭(HF)、急性心肌梗死(AMI)、糖尿病和原发性高血压。竞争风险分析显示,80岁以上人群的亚分布风险比(SHR)为6.53 [95%置信区间:4.65 - 9.19]。心力衰竭与较低的全因风险比[0.80,95%置信区间:0.76 - 0.86,p < 0.001]相关,但与较高的SHR[1.30,95%置信区间:1.18 - 1.44,p < 0.001]相关。心力衰竭、中风和急性心肌梗死等合并症显著增加死亡风险,而原发性高血压与较低的死亡风险相关。

结论

PAD发病率的显著上升凸显了该疾病负担的不断增加,突出了哈萨克斯坦针对性预防和管理策略的迫切需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ca/11652560/cd0a63d79c64/44197_2024_313_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ca/11652560/9d76a8632afe/44197_2024_313_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ca/11652560/cd0a63d79c64/44197_2024_313_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ca/11652560/9d76a8632afe/44197_2024_313_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ca/11652560/cd0a63d79c64/44197_2024_313_Fig2_HTML.jpg

相似文献

1
Temporal Trends and Mortality Patterns in Peripheral Arterial Disease: A Comprehensive Analysis of Hospitalized Patients in Kazakhstan between 2014 and 2021.外周动脉疾病的时间趋势和死亡率模式:对2014年至2021年哈萨克斯坦住院患者的综合分析
J Epidemiol Glob Health. 2024 Dec;14(4):1609-1618. doi: 10.1007/s44197-024-00313-6. Epub 2024 Oct 14.
2
Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.外周动脉疾病是男性和女性的冠心病等效风险:一项全国性研究的结果。
Eur J Prev Cardiol. 2015 Mar;22(3):317-25. doi: 10.1177/2047487313519344. Epub 2014 Jan 7.
3
Peripheral artery disease is associated with high in-hospital mortality particularly in males with acute myocardial infarction in a nationwide real-world setting.在全国范围内的真实世界环境中,外周动脉疾病与高住院死亡率相关,尤其是在患有急性心肌梗死的男性中。
Vasa. 2016;45(2):169-74. doi: 10.1024/0301-1526/a000512.
4
Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.外周动脉疾病作为动脉粥样硬化疾病初始或后续表现患者的心血管结局:一项瑞典全国性研究的结果
J Vasc Surg. 2017 Aug;66(2):507-514.e1. doi: 10.1016/j.jvs.2017.01.067. Epub 2017 Apr 19.
5
Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.指南推荐的降低风险方案对改善外周动脉疾病患者心血管和肢体结局的疗效。
JAMA Surg. 2016 Aug 1;151(8):742-50. doi: 10.1001/jamasurg.2016.0415.
6
Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: trends between 1997 and 2016.外周动脉疾病患者中心肌梗死、心力衰竭及心血管疾病死亡率的发生率:1997年至2016年的趋势
Eur Heart J Qual Care Clin Outcomes. 2023 Feb 28;9(2):142-149. doi: 10.1093/ehjqcco/qcac022.
7
Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.外周动脉疾病与心肌梗死后结局:CAPRICORN、EPEHESUS、OPTIMAL 和 VALIANT 研究 28771 例患者的个体患者荟萃分析。
Int J Cardiol. 2013 Sep 30;168(2):1094-101. doi: 10.1016/j.ijcard.2012.11.033. Epub 2012 Nov 26.
8
Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID.心力衰竭与外周动脉疾病患者结局的相关性:EUCLID 的见解。
J Am Heart Assoc. 2021 Jun 15;10(12):e018684. doi: 10.1161/JAHA.120.018684. Epub 2021 May 31.
9
Impact of betablockers on general and local outcome in patients hospitalized for lower extremity peripheral artery disease: The COPART Registry.β受体阻滞剂对因下肢外周动脉疾病住院患者的总体和局部预后的影响:COPART注册研究
Medicine (Baltimore). 2017 Feb;96(5):e5916. doi: 10.1097/MD.0000000000005916.
10
The association of comorbid depression with mortality and amputation in veterans with peripheral artery disease.合并抑郁与外周动脉疾病退伍军人死亡率和截肢的相关性。
J Vasc Surg. 2018 Aug;68(2):536-545.e2. doi: 10.1016/j.jvs.2017.10.092. Epub 2018 Mar 24.

本文引用的文献

1
Incidence, mortality and disability-adjusted life years of acute myocardial infarction in Kazakhstan: data from unified national electronic healthcare system 2014-2019.哈萨克斯坦急性心肌梗死的发病率、死亡率和伤残调整生命年:来自2014 - 2019年国家统一电子医疗系统的数据
Front Cardiovasc Med. 2023 Aug 2;10:1127320. doi: 10.3389/fcvm.2023.1127320. eCollection 2023.
2
Obesity and Peripheral Artery Disease: Current Evidence and Controversies.肥胖与外周动脉疾病:当前证据与争议。
Curr Obes Rep. 2023 Sep;12(3):264-279. doi: 10.1007/s13679-023-00510-7. Epub 2023 May 27.
3
Accessibility and quality of medical care for patients with chronic noncommunicable diseases during COVID-19 pandemic.
COVID-19 大流行期间慢性非传染性疾病患者的医疗可及性和质量。
NPJ Prim Care Respir Med. 2023 Mar 31;33(1):14. doi: 10.1038/s41533-023-00328-9.
4
Obesity Paradox: Fact or Fiction?肥胖悖论:事实还是虚构?
Curr Obes Rep. 2023 Jun;12(2):75-85. doi: 10.1007/s13679-023-00497-1. Epub 2023 Feb 20.
5
The global burden of peripheral artery disease.外周动脉疾病的全球负担。
J Vasc Surg. 2023 Apr;77(4):1119-1126.e1. doi: 10.1016/j.jvs.2022.12.015. Epub 2022 Dec 21.
6
Review of the research databases on population-based Registries of Unified electronic Healthcare system of Kazakhstan (UNEHS): Possibilities and limitations for epidemiological research and Real-World Evidence.哈萨克斯坦统一电子医疗系统(UNEHS)基于人群登记处的研究数据库综述:流行病学研究和真实世界证据的可能性与局限性
Int J Med Inform. 2023 Feb;170:104950. doi: 10.1016/j.ijmedinf.2022.104950. Epub 2022 Dec 7.
7
Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014-2019.哈萨克斯坦 1 型和 2 型糖尿病的流行病学:来自 2014-2019 年统一国家电子健康系统的数据。
BMC Endocr Disord. 2022 Nov 11;22(1):275. doi: 10.1186/s12902-022-01200-6.
8
Incidence and mortality rates of strokes in Kazakhstan in 2014-2019.2014-2019 年哈萨克斯坦脑卒中发病率和死亡率。
Sci Rep. 2022 Sep 26;12(1):16041. doi: 10.1038/s41598-022-20302-8.
9
Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004-2017.哈萨克斯坦共和国心血管疾病的发病率和死亡率:2004 - 2017年
Iran J Public Health. 2022 Apr;51(4):821-830. doi: 10.18502/ijph.v51i4.9243.
10
Epidemiology of Peripheral Artery Disease: Narrative Review.外周动脉疾病的流行病学:叙述性综述
Life (Basel). 2022 Jul 12;12(7):1041. doi: 10.3390/life12071041.